What Do Children Really Understand About Covid?

United States News News

What Do Children Really Understand About Covid?
United States Latest News,United States Headlines
  • 📰 PsychToday
  • ⏱ Reading Time:
  • 69 sec. here
  • 3 min. at publisher
  • 📊 Quality Score:
  • News: 31%
  • Publisher: 51%

How well do children grasp the risks and realities of COVID? They might be savvier than you think.

Previous studies of how children understand concepts of illness, germs, contagion and infection are helpful.

In early March 2020 – yes, it seems like a century ago — in most places the first lockdowns made clear the chilling reality of what would soon be declared a worldwide pandemic. The rollercoaster ride of one wave followed by a reprieve followed by another surge has left us all exhausted and drained. Vaccines have raised hopes but the Delta variant, and the specter of yet more deadly and contagious future variants, have dashed those hopes once again.

And now, another school year opens in the Age of Covid. For parents, caregivers, and family members, the nagging question is: “How safe will my child be in the classroom?” More broadly, as we move toward the third year of Covid, with no end in sight, we confront an unsettling thought: Our children are growing up in a Covid world. Even if we can keep them safe from infection and disease—a big IF—we cannot shield them from the larger reality.

These results, and others like them, suggest that children can understand the basic mechanisms of infectious respiratory diseases. By implication, then, they also probably readily grasp the utility of measures that interrupt modes of transmission. If you can"catch" a novel disease when a friend sneezes and coughs all over you, then preventing that through masking, sanitation, and distancing should be easily understood as well.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

PsychToday /  🏆 714. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Pfizer says COVID-19 vaccine works in kids ages 5 to 11, will seek authorizationPfizer says COVID-19 vaccine works in kids ages 5 to 11, will seek authorizationPfizer said its COVID-19 vaccine works for children ages 5 to 11 and that it will seek U.S. authorization for this age group soon.
Read more »

Long Covid Affecting One Third Of People After Covid-19 Coronavirus Infection, CDC MMWR Study FindsLong Covid Affecting One Third Of People After Covid-19 Coronavirus Infection, CDC MMWR Study FindsSymptom rates were higher among females, Black people, and those 40 years and older or with pre-existing conditions.
Read more »

Pfizer says its COVID-19 vaccine is safe and effective for children ages 5 to 11Pfizer says its COVID-19 vaccine is safe and effective for children ages 5 to 11Pfizer and its German partner, BioNTech, said they would submit their data to the FDA for emergency use authorization.
Read more »

Pfizer and BioNTech say COVID-19 vaccine safe and effective in children aged 5 to 11Pfizer and BioNTech say COVID-19 vaccine safe and effective in children aged 5 to 11Pfizer Inc. undefined and German partner BioNTech SE undefined on Monday announced positive results in a Phase 2/3 trial of their COVID-19 vaccine in...
Read more »

Nearly 226,000 Covid-19 cases were reported in children last week, pediatrician group saysNearly 226,000 Covid-19 cases were reported in children last week, pediatrician group saysCovid-19 infections have continued to increase 'exponentially' among children across the US, and now account for nearly 26% of all cases reported nationwide, according to data published Monday.
Read more »

Upbeat result of COVID-19 vaccine trial in 5- to 11-year-olds tempered as U.S. daily death rate tops 2,000 for first time since March 1Upbeat result of COVID-19 vaccine trial in 5- to 11-year-olds tempered as U.S. daily death rate tops 2,000 for first time since March 1“The antibody responses in the participants given 10 ug doses were comparable to those recorded in a previous Pfizer-BioNTech study in people 16 to 25 years of age immunized with 30 ug doses,” the companies said in a joint statement.
Read more »



Render Time: 2025-02-25 06:24:36